SIRT6c therapy lowers biological age in dogsA study of 24 dogs showed reduced biological age and muscle improvements after receiving GF-1004 plasmid DNA therapy.
Longevity.TechnologyLongevity
- Field
- gene therapy
- What they did
- Researchers conducted a trial of SIRT6c gene therapy on 24 aging dogs to test if it can slow biological aging and improve muscle health without causing harm.
- Why it matters
- Results showed preliminary signs of reduced biological age and muscle improvements, which could be useful for developing life-extension methods for humans.
#sirt6c#gene therapy#aging#beagle#sarcopenia
Read the original →